Form
SCHEDULE 13D/A
Active or control-oriented beneficial ownership filing.
Bindley Capital Partners I, LLC - 29 Jul 2025 SCHEDULE 13D/A Report for Guardian Pharmacy Services, Inc. Class A Common Stock, par value $0.001 per share (GRDN)
- Filing manager
- Bindley Capital Partners I, LLC
- Reporting owner
- Thomas J. Salentine, Jr.
- Beneficially owned shares
- 8,075,707 shares
- Large-stake signal
-
Ownership
22%Beneficial ownership of this reported class.
Shares
8,075,707 sharesShares beneficially owned as disclosed.
Event date
29 Jul 2025Date tied to the ownership event or amendment.
Accepted by SEC
29 Jul 2025EDGAR acceptance date.
How to read this large-stake filing
- Schedule 13D/G filings focus on beneficial ownership stakes, not a full portfolio.
- Compare this filing with the holder history and issuer page before treating the percentage as a current position.
- Use amendments to understand whether the disclosed stake increased, decreased, or changed reporting status.
- Class ownership
- 22%
- Symbol
- GRDN
- Shares outstanding
- 36,213,933 shares
- SEC form
- SCHEDULE 13D/A
- Accepted by SEC
- 29 Jul 2025, 16:54:45 UTC
- Event date
- 29 Jul 2025
- Prior SEC filing
- 29 May 2025
- Next SEC filing
- 24 Mar 2026
- Source filing
- View source filing
Ownership signal
CIK-linked ownership evidence from parsed SEC filings.
2 signals
Subject security
Names, identifiers, and filing context for this profile.
2 source fields
Source evidence
Original filing metadata and source links for verification.
6 source fields
Key filing fact
Bindley Capital Partners I, LLC disclosed 22% ownership in Guardian Pharmacy Services, Inc. Class A Common Stock, par value $0.001 per share (GRDN) on 29 Jul 2025.
Key facts
- Bindley Capital Partners I, LLC filed SCHEDULE 13D/A for Guardian Pharmacy Services, Inc. Class A Common Stock, par value $0.001 per share (GRDN).
- Disclosed ownership: 22%.
- Date of event: 29 Jul 2025.
Change
- Previous schedule filing date: 29 May 2025.
- Current filing was accepted on 29 Jul 2025, 16:54.
Research use
- This page turns one Schedule 13D/G filing into a quick large-stake read before the raw reporting-person rows.
- Use the linked SEC filing as the source of truth for ownership percentages, shares, and reporting-party details.
Evidence
Backed by Schedule 13D/13G
View source filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting persons
Disclosed reporting parties (9)
Names, ownership percentages, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.
| Name | Ownership | Shares owned | Sole voting power | Shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Bindley Capital Partners I, LLC | 22% | 8,039,993 | 8,039,993 | 0 | /s/ Thomas J. Salentine, Jr. | Member | 0002038820 |
| William E. Bindley | 22% | 8,039,993 | 0 | 8,039,993 | /s/ William E. Bindley, individually | William E. Bindley, individually | 0000903539 |
| Thomas J. Salentine, Jr. | 22% | 8,075,707 | 35,714 | 8,039,993 | /s/ Thomas J. Salentine, Jr., individually | Thomas J. Salentine, Jr., individually | 0002037899 |
| Pharmacy Investors, LLC | 5.1% | 1,863,564 | 1,863,564 | 0 | /s/ John Ackerman | Managing Member | 0002038519 |
| John Ackerman | 5.1% | 1,863,564 | 1,863,564 | 0 | /s/ John Ackerman, individually | John Ackerman, individually | 0002037898 |
| Cardinal Equity Fund, L.P. | 1.7% | 620,851 | 620,851 | 0 | /s/ John Ackerman, by Cardinal Equity Partners, LLC, its General Partner | Managing Member | 0001432819 |
| Fred P. Burke | 4.7% | 1,711,845 | 1,711,845 | 0 | /s/ Fred P. Burke, individually | Fred P. Burke, individually | 0002037972 |
| David K. Morris | 2.3% | 845,979 | 845,979 | 0 | /s/ David K. Morris, individually | David K. Morris, individually | 0002037977 |
| G. Kendall Forbes | 2.2% | 802,091 | 802,091 | 0 | /s/ G. Kendall Forbes, individually | G. Kendall Forbes, individually | 0002038507 |
CIK / CUSIP context first